Compare Canopy Growth Corp (CGC) vs KB Financial Group, Inc. (KB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Canopy Growth Corp vs KB Financial Group, Inc. — how do they compare? Canopy Growth Corp trades at $1.03 (market cap $421.10M), while KB Financial Group, Inc. trades at $117.78 (market cap $41.21B). The key difference: KB Financial Group, Inc. is far larger — about 97.9× Canopy Growth Corp's market cap, and KB Financial Group, Inc. pays a 2.67% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| CGC | KB | |
|---|---|---|
Market Cap | $421.10M | $41.21B |
Sector | Health | Financials |
52-Week High | $1.92 | $124.01 |
52-Week Low | $0.86 | $77.50 |
Enterprise Value | $378.55M | — |
Dividend Yield | — | 2.67% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $1.02, up 7.13% with a bullish technical signal. The company reported Q1 fiscal 2027 revenue growth of 13% to C$81.2 million and narrowed its EBITDA loss. While revenue trends show stabilization after declining from $520M in 2022 to $269M in 2025, the company continues to post significant net losses with a -222.36% margin. The balance sheet shows improvement with debt-to-asset ratio declining from 53.61% in 2023 to 33.13% in 2025.
CGC presents a high-risk opportunity with potential catalysts from cannabis rescheduling and European expansion. The stock trades below book value (P/B 0.86) but faces substantial execution risks amid persistent losses. Analyst sentiment is mixed with 33% buy ratings, reflecting optimism about restructuring progress versus concerns about profitability timeline.
KB Financial trades at $117.63, down 2.57% today, with a bullish technical signal from moving averages. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and rising revenue ($21.23T in 2025). Valuation metrics appear attractive with a P/E of 10.36 and P/B below 1. Recent news highlights momentum and dividend potential, while cash flow trends show volatility with a net inflow of $4.41T in 2025.
The outlook remains positive given earnings momentum and diversification into non-banking segments (43% of earnings). Risks include volatile cash flows and macroeconomic sensitivity. Analysts are mixed (33% Buy, 67% Hold), suggesting cautious optimism. The stock's current price near support at $117 offers a potential entry, but investors should monitor execution on non-banking targets and interest rate impacts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Canopy Growth Corp
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →About KB Financial Group, Inc.
KB Financial is the parent company of KB Kookmin Bank, Korea's largest commercial bank, with a 13.1% share of loans as of 2021. Its predecessor banks were established in the 1960s as government policy banks and privatized in the 1990s. Its credit card subsidiary KB Kookmin Card is the number-three player behind Shinhan Card and Samsung Card. KB has in recent years expanded its nonbank business by buying LIG Insurance and Hyundai Securities, making KB a top-five player in nonlife insurance and in securities, and most recently by buying Prudential Life Insurance Korea. It also has KB Capital, which provides leasing and installment finance.
Read more on KB →
